Discovery of new membrane-associated proteins overexpressed in small-cell lung cancer

Journal of Thoracic Oncology

Volumn 9, Issue 3, 2014, Pages 324-336

  Ocak, Sebahat ^a,b   Friedman, David B ^c   Chen, Heidi ^d   Ausborn, Jamie A ^c   Hassanein, Mohamed ^d   Detry, Bruno ^h   Weynand, Birgit ^b   Aboubakar, Frank ^h   Pilette, Charles ^e   Sibille, Yves ^f   Massion, Pierre P ^d,f,g  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^f VANDERBILT INGRAM CANCER CENTER   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h NONE

Author keywords

Biomarker; Membrane associated; Proteomics; Small cell lung cancer

Indexed keywords

COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; LAMININ RECEPTOR; MEMBRANE ASSOCIATED PROTEIN; MEMBRANE PROTEIN; NUCLEOTIDE BINDING PROTEIN; STATHMIN; UNCLASSIFIED DRUG;

ARTICLE; BRONCHUS MUCOSA; CONTROLLED STUDY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY; WESTERN BLOTTING;

ADENOCARCINOMA; AGED; BLOTTING, WESTERN; BRONCHI; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELLS, CULTURED; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SMALL CELL LUNG CARCINOMA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84894556198     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000090     Document Type: Article

References (40)

1. Jackman DM, Johnson BE. Small-cell lung cancer. Lancet 2005;366:1385-1396.
2. Ocak S, Chaurand P, Massion PP. Mass spectrometry-based proteomic profiling of lung cancer. Proc Am Thorac Soc 2009;6:159-170.
3. Ocak S, Sos ML, Thomas RK, Massion PP. High-Throughput molecular analysis in lung cancer: Insights into biology and potential clinical applications. Eur Respir J 2009;34:489-506.
4. Alfonso P, Núñez A, Madoz-Gurpide J, Lombardia L, Sánchez L, Casal JI. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis. Proteomics 2005;5:2602-2611.
5. Evans CA, Tonge R, Blinco D, et al. Comparative proteomics of primitive hematopoietic cell populations reveals differences in expression of proteins regulating motility. Blood 2004;103:3751-3759.
6. Seike M, Kondo T, Fujii K, et al. Proteomic signatures for histological types of lung cancer. Proteomics 2005;5:2939-2948.
7. Yildirim MA, Goh KI, Cusick ME, Barabási AL, Vidal M. Drug-Target network. Nat Biotechnol 2007;25:1119-1126.
8. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-Throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-847.
9. Friedman DB, Wang SE, Whitwell CW, Caprioli RM, Arteaga CL. Multivariable difference gel electrophoresis and mass spectrometry: A case study on transforming growth factor-beta and ERBB2 signaling. Mol Cell Proteomics 2007;6:150-169.
10. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/ MS and database search. Anal Chem 2002;74:5383-5392.
11. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003;75:4646-4658.
12. Massion PP, Taflan PM, Jamshedur Rahman SM, et al. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res 2003;63:7113-7121.
13. Ziv T, Barnea E, Segal H, et al. Comparative proteomics of small cell lung carcinoma. Cancer Biomark 2006;2:219-234.
14. Jeong HC, Kim GI, Cho SH, et al. Proteomic analysis of human small cell lung cancer tissues: Up-regulation of coactosin-like protein-1. J Proteome Res 2011;10:269-276.
15. Eriksson H, Lengqvist J, Hedlund J, et al. Quantitative membrane proteomics applying narrow range peptide isoelectric focusing for studies of small cell lung cancer resistance mechanisms. Proteomics 2008;8:3008-3018.
16. Gavet O, Ozon S, Manceau V, Lawler S, Curmi P, Sobel A. The stathmin phosphoprotein family: Intracellular localization and effects on the microtubule network. J Cell Sci 1998;111 (Pt 22):3333-3346.
17. Niethammer P, Bastiaens P, Karsenti E. Stathmin-Tubulin interaction gradients in motile and mitotic cells. Science 2004;303:1862-1866.
18. Nemunaitis J. Stathmin 1: A protein with many tasks. New biomarker and potential target in cancer. Expert Opin Ther Targets 2012;16:631-634.
19. Peifer M, Fernández-Cuesta L, Sos ML, et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet 2012;44:1104-1110.
20. Chen G, Wang H, Gharib TG, et al. Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas. Mol Cell Proteomics 2003;2:107-116.
21. Singer S, Malz M, Herpel E, et al. Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer. Cancer Res 2009;69:2234-2243.
22. Pisanu S, Ghisaura S, Pagnozzi D, et al. The sheep milk fat globule membrane proteome. J Proteomics 2011;74:350-358.
23. Tanca A, Addis MF, Pagnozzi D, et al. Proteomic analysis of formalin-fixed, paraffin-embedded lung neuroendocrine tumor samples from hospital archives. J Proteomics 2011;74:359-370.
24. Hensley K, Venkova K, Christov A, Gunning W, Park J. Collapsin response mediator protein-2: An emerging pathologic feature and therapeutic target for neurodisease indications. Mol Neurobiol 2011;43:180-191.
25. Tabarés-Seisdedos R, Rubenstein JL. Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: Implications for schizophrenia, autism and cancer. Mol Psychiatry 2009;14:563-589.
26. Küsters-Vandevelde HV, Klaasen A, Küsters B, et al. Activating mutations of the GNAQ gene: A frequent event in primary melanocytic neoplasms of the central nervous system. Acta Neuropathol 2010;119:317-323.
27. Romano E, Schwartz GK, Chapman PB, Wolchock JD, Carvajal RD. Treatment implications of the emerging molecular classification system for melanoma. Lancet Oncol 2011;12:913-922.
28. Lamba S, Felicioni L, Buttitta F, et al. Mutational profile of GNAQQ209 in human tumors. PLoS One 2009;4:e6833.
29. Bellosta P, Hulf T, Balla Diop S, et al. Myc interacts genetically with Tip48/Reptin and Tip49/Pontin to control growth and proliferation during Drosophila development. Proc Natl Acad Sci U S A 2005;102:11799-11804.
30. Hawley SB, Tamura T, Miles LA. Purification, cloning, and characterization of a profibrinolytic plasminogen-binding protein, TIP49a. J Biol Chem 2001;276:179-186.
31. Dehan E, Ben-Dor A, Liao W, et al. Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung Cancer 2007;56:175-184.
32. Lauscher JC, Elezkurtaj S, Dullat S, et al. Increased Pontin expression is a potential predictor for outcome in sporadic colorectal carcinoma. Oncol Rep 2012;28:1619-1624.
33. Elkaim J, Castroviejo M, Bennani D, et al. First identification of small-molecule inhibitors of Pontin by combining virtual screening and enzymatic assay. Biochem J 2012;443:549-559.
34. Cioce V, Castronovo V, Shmookler BM, et al. Increased expression of the laminin receptor in human colon cancer. J Natl Cancer Inst 1991;83:29-36.
35. Ménard S, Castronovo V, Tagliabue E, Sobel ME. New insights into the metastasis-Associated 67 kD laminin receptor. J Cell Biochem 1997;67:155-165.
36. Ménard S, Tagliabue E, Colnaghi MI. The 67 kDa laminin receptor as a prognostic factor in human cancer. Breast Cancer Res Treat 1998;52:137-145.
37. Satoh K, Narumi K, Isemura M, et al. Increased expression of the 67kDa-laminin receptor gene in human small cell lung cancer. Biochem Biophys Res Commun 1992;182:746-752.
38. Wewer UM, Taraboletti G, Sobel ME, Albrechtsen R, Liotta LA. Role of laminin receptor in tumor cell migration. Cancer Res 1987;47:5691-5698.
39. Fontanini G, Vignati S, Chiné S, et al. 67-Kilodalton laminin receptor expression correlates with worse prognostic indicators in non-small cell lung carcinomas. Clin Cancer Res 1997;3:227-231.
40. Shin BK, Wang H, Yim AM, et al. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J Biol Chem 2003;278:7607-7616.